CHANGES IN PHARMACOKINETICS OF ANTI-HIV PROTEASE INHIBITORS DURING PREGNANCY: THE ROLE OF CYP3A AND P-GLYCOPROTEIN

Anita A. Mathias; Lillian Maggio-Price; Yurong Lai; Anshul Gupta; Jashvant D. Unadkat

doi:10.1124/jpet.105.095406

OtherAbsorption, Distribution, Metabolism, and Excretion

CHANGES IN PHARMACOKINETICS OF ANTI-HIV PROTEASE INHIBITORS DURING PREGNANCY: THE ROLE OF CYP3A AND P-GLYCOPROTEIN

Anita A. Mathias, Lillian Maggio-Price, Yurong Lai, Anshul Gupta and Jashvant D. Unadkat

Journal of Pharmacology and Experimental Therapeutics November 17, 2005, DOI: https://doi.org/10.1124/jpet.105.095406

Anita A. Mathias

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lillian Maggio-Price

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yurong Lai

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anshul Gupta

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jashvant D. Unadkat

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
eLetters
PDF

This is a PDF-only article. The first page of the PDF of this article appears below.

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 362, Issue 2

1 Aug 2017

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following CHANGES IN PHARMACOKINETICS OF ANTI-HIV PROTEASE INHIBITORS DURING PREGNANCY: THE ROLE OF CYP3A AND P-GLYCOPROTEIN

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

Citation Tools

OtherAbsorption, Distribution, Metabolism, and Excretion

CHANGES IN PHARMACOKINETICS OF ANTI-HIV PROTEASE INHIBITORS DURING PREGNANCY: THE ROLE OF CYP3A AND P-GLYCOPROTEIN

Anita A. Mathias, Lillian Maggio-Price, Yurong Lai, Anshul Gupta and Jashvant D. Unadkat

Journal of Pharmacology and Experimental Therapeutics November 17, 2005, DOI: https://doi.org/10.1124/jpet.105.095406

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

OtherAbsorption, Distribution, Metabolism, and Excretion

CHANGES IN PHARMACOKINETICS OF ANTI-HIV PROTEASE INHIBITORS DURING PREGNANCY: THE ROLE OF CYP3A AND P-GLYCOPROTEIN

Anita A. Mathias, Lillian Maggio-Price, Yurong Lai, Anshul Gupta and Jashvant D. Unadkat

Journal of Pharmacology and Experimental Therapeutics November 17, 2005, DOI: https://doi.org/10.1124/jpet.105.095406

Permalink:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Info & Metrics
eLetters
PDF

Main menu

User menu

Search

CHANGES IN PHARMACOKINETICS OF ANTI-HIV PROTEASE INHIBITORS DURING PREGNANCY: THE ROLE OF CYP3A AND P-GLYCOPROTEIN

In this issue

CHANGES IN PHARMACOKINETICS OF ANTI-HIV PROTEASE INHIBITORS DURING PREGNANCY: THE ROLE OF CYP3A AND P-GLYCOPROTEIN

Citation Manager Formats

CHANGES IN PHARMACOKINETICS OF ANTI-HIV PROTEASE INHIBITORS DURING PREGNANCY: THE ROLE OF CYP3A AND P-GLYCOPROTEIN

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals